VBI Vaccines Inc Forbearance Agreements
7 Contracts & Agreements
- Extension to Forbearance Agreement, dated February 6, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated January 23, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated January 9, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated December 26, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated December 12, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated November 28, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on April 16, 2024)
- Forbearance Agreement, dated November 13, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (Filed With SEC on November 14, 2023)
